全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
化学进展  2013 

增生平用于口腔癌化学预防

DOI: 10.7536/PC130720, PP. 1594-1600

Keywords: 增生平,中药复方,动物模型,口腔癌,口腔白斑

Full-Text   Cite this paper   Add to My Lib

Abstract:

增生平(ZSP,又称anti-tumorB,ATB)是一种由山豆根、拳参、北败酱、夏枯草、白鲜皮、黄药子等组成的中药复方。以前的研究显示增生平对人食管癌(主要是鳞状细胞癌)有显著的化学预防效用。我们系统地研究评价了增生平对4-硝基喹啉-1-氧化物诱导的A/J小鼠口腔癌发生发展的影响,发现增生平减少了约60%的口腔癌。对7,12-二甲苯并(a)蒽诱导的仓鼠口腔癌也观察到了类似的结果。进而在口腔白斑患者中开展了一个随机临床实验,结果发现增生平(每日三次,每次4片,持续8—12个月)在68%的患者中减少了口腔病变的大小,而在安慰剂组只有17%(P<0.01)。这些结果显示增生平可能是一种强效的人口腔癌化学预防试剂。

References

[1]  Spitz M R. Semin. Oncol., 1994, 21: 281–288
[2]  Jemal A, Siegel R, Xu J, Ward E. CA Cancer J. Clin., 2010, 60(5): 277—300
[3]  Forastiere A, Koch W, Trotti A, Sidransky D. N. Engl. J. Med., 2001, 345(26): 1890—1900
[4]  Steidler N E, Reade P C. Oral Surg. Oral. Med. Oral Pathol., 1984, 57: 524—531
[5]  Wang Y, Yao R, Gao S, Wen W, Du Y, Szabo E, Hu M, Lubet R A, You M. Mol. Carcinog., 2013, 52(1): 49—56
[6]  Gao G, Law F C. Drug Metab. Dispos., 2009, 37: 884—891
[7]  Christensen M E, Therkildsen M H, Hansen B L, Albeck H, Hensen G N, Bretlau P. Eur. Arch. Otorhinolaryngol., 1992, 249: 243—247
[8]  Hiraishi Y, Wada T, Nakatani K, Negoro K, Fujita S. Pathol. Oncol. Res., 2006, 12: 87—91
[9]  Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M, Norer B. Oral Oncol., 2007, 43: 193—198
[10]  Sarkis S A, Abdullah B H, Abdul M B A, Talabani N G. Head Neck Oncol., 2010, 2: 13
[11]  Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Clerici M, Formelli F, Barzan L, Carrassi A, et al. Eur. J. Cancer B, Oral Oncol., 1992, 28B: 97—102
[12]  Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Formelli F, Giardini R, Costa A, De Palo G, et al. J. Cell. Biochem. Suppl., 1993, 17F: 255—261
[13]  Benner S E, Winn R J, Lippman S M, Poland J, Hansen K S, Luna M A, Hong W K. J. Natl. Cancer Inst., 1993, 85: 44—47
[14]  Shumway B S, Kresty L A, Larsen P E, Zwick J C, Lu B, Fields H W, Mumper R J, Stoner G D, Mallery S R. Clin. Cancer Res., 2008, 14: 2421—2430
[15]  Awad A B, Fink C S. J. Nutr., 2000, 130: 2127—2130
[16]  Awad A B, Gan Y, Fink C S. Nutr. Cancer, 2000, 36: 74—78
[17]  Rao A V, Janezic S A. Nutr. Cancer, 1992, 18: 43—52
[18]  von Holtz R L, Fink C S, Awad A B. Nutr. Cancer, 1998, 32: 8—12
[19]  Sun Z, Guan X, Li N, Liu X, Chen X. Oral Oncol., 2010, 46: 105—110
[20]  Lin P Z, Zhang J S, Cao S G, Rong Z P, Gao R Q, Han R, Shu S P. Chinese Journal of Oncology, 1988, 10: 161—166
[21]  Lin P, Zhang J, Rong Z, Han R, Xu S, Gao R, Ding Z, Wang J, Feng H, Cao S. Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll., 1990, 5: 121—129
[22]  Lin P. Acta Academiae Medicinae Sinicae, 1990, 12: 235—245
[23]  Fan X. Acta Academiae Medicinae Sinicae, 1993, 15: 71—73
[24]  Zhang Z, Wang Y, Yao R, Li J, Yan Y, La Regina M, Lemon W L, Grubbs C J, Lubet R A, You M. Oncogene, 2004, 23: 3841—3850
[25]  Wang Y, Zhang Z, Garbow J R, Rowland D J, Lubet R A, Sit D, Law F, You M. Cancer Prev. Res. (Phila), 2009, 2: 634—640
[26]  Andre K, Schraub S, Mercier M, Bontemps P. Eur. J. Cancer B Oral Oncol., 1995, 31B: 301—309
[27]  Iribarren C, Tekawa I S, Sidney S, Friedman G D. N. Engl. J. Med., 1999, 340: 1773—1780
[28]  Murata M, Takayama K, Choi B C, Pak A W. Cancer Detect. Prev., 1996, 20: 557—565
[29]  Winn D M. Adv. Exp. Med. Biol., 1992, 320: 39—46
[30]  周曾同(Zhou Z T). 中华口腔医学杂志(Chinese Journal of Stomatology), 2006, 41(8): 502—505
[31]  Yuan B, Heniford B W, Ackermann D M, Hawkins B L, Hendler F J. Cancer Res., 1996, 54: 5310—5317
[32]  Zhang Z, Wang Y, Yao R, Lubet R A, You M. Mol. Cancer Res., 2006, 4: 401—410
[33]  Gao G. Comparative pharmacokinetics of matrine: pure matrine vs crude chemical in ACAPHA. Doctoral Dissertation, Simon Fraser University, Burnaby, British Columbia, Canada, 2007
[34]  Guan X B, Sun Z, Chen X X, Wu H R, Zhang X Y. Chin. Med. J. (Engl), 2012, 125: 332—337
[35]  Garewal H. Eur. J. Cancer Prev., 1994, 3: 101—107
[36]  Sankaranarayanan R, Mathew B, Varghese C, Sudhakaran P R, Menon V, Jayadeep A, Nair M K, Mathews C, Mahalingam T R, Balaram P, Nair P P. Oral Oncol., 1997, 33: 231—236
[37]  Armstrong W B, Kennedy A R, Wan X S, Taylor T H, Nguyen Q A, Jensen J, Thompson W, Lagerberg W, Meyskens F L Jr. Clin. Cancer Res., 2000, 6: 4684—4691
[38]  Halder A, Raychowdhury R, Ghosh A, De M. J. Environ. Pathol. Toxicol. Oncol., 2005, 24: 141—144
[39]  Raicht R F, Cohen B I, Fazzini E, Sarwal A, Takahashi M. J. Cancer Res., 1980, 40: 403—405
[40]  Awad A B, Down A C, Fink C S. Int. J. Mol. Med., 2000, 5: 541—546
[41]  Awad A B, Downie A C, Fink C S, Kim U. Anticancer Res., 2000, 20: 821—824
[42]  Awad A B, Williams H, Fink C S. Nutr. Cancer, 2001, 40: 157—164

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133